P

recision medicine is on the rise, and for good reason: Many drugs on the market work for only a specific subset of patients, so there is an urgent need to better match patients and treatments.

The field is rife with opportunity, but also faces challenges, as highlighted in a new annual report from the Personalized Medicine Coalition. The number of precision medicine drugs is growing steadily:

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.